company background image
1PR1 logo

Citrine Global BST:1PR1 Stock Report

Last Price

€0.015

Market Cap

€16.2m

7D

0%

1Y

-46.4%

Updated

30 Jul, 2022

Data

Company Financials

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

1PR1 Stock Overview

Operates as a plant-based wellness and pharma solutions company in Israel.

1PR1 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Citrine Global Corp. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Citrine Global
Historical stock prices
Current Share PriceUS$0.015
52 Week HighUS$0.10
52 Week LowUS$0.011
Beta1.27
11 Month Change25.00%
3 Month Change20.00%
1 Year Change-46.43%
33 Year Change-87.33%
5 Year Change-96.25%
Change since IPO-96.88%

Recent News & Updates

Recent updates

Shareholder Returns

1PR1DE Personal ProductsDE Market
7D0%5.8%4.5%
1Y-46.4%10.2%13.5%

Return vs Industry: 1PR1 underperformed the German Personal Products industry which returned -4.7% over the past year.

Return vs Market: 1PR1 underperformed the German Market which returned -17.8% over the past year.

Price Volatility

Is 1PR1's price volatile compared to industry and market?
1PR1 volatility
1PR1 Average Weekly Movement10.8%
Personal Products Industry Average Movement4.6%
Market Average Movement5.0%
10% most volatile stocks in DE Market11.6%
10% least volatile stocks in DE Market2.4%

Stable Share Price: 1PR1's share price has been volatile over the past 3 months.

Volatility Over Time: 1PR1's weekly volatility has decreased from 24% to 11% over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
201018Ora Sofferwww.citrine-global.com

Citrine Global Corp. operates as a plant-based wellness and pharma solutions company. It focuses on developing plant-based products to enhance quality of life, and complementary solutions for balancing side effects caused by using medicines, cannabis, treatments, or an unbalanced lifestyle. The company was formerly known as TechCare Corp. and changed its name to Citrine Global Corp. in August 2020.

Citrine Global Corp. Fundamentals Summary

How do Citrine Global's earnings and revenue compare to its market cap?
1PR1 fundamental statistics
Market cap€16.17m
Earnings (TTM)-€3.08m
Revenue (TTM)n/a

0.0x

P/S Ratio

-5.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1PR1 income statement (TTM)
RevenueUS$0
Cost of RevenueUS$0
Gross ProfitUS$0
Other ExpensesUS$3.15m
Earnings-US$3.14m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.0033
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio-93.6%

How did 1PR1 perform over the long term?

See historical performance and comparison